Cost-effectiveness of timely versus delayed primary total hip replacement in Germany: A social health insurance perspective

by Ruben E. Mujica-Mota, Leala K. Watson, Rosanna Tarricone, Marcus Jäger
Published 2017-10-01

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe.

by Antonieta Medina Lara, Jesse Kigozi, Jovita Amurwon, Lazarus Muchabaiwa, Barbara Nyanzi Wakaholi, Ruben E Mujica Mota, A Sarah Walker, Ronnie Kasirye, Francis Ssali, Andrew Reid, Heiner Grosskurth, Abdel G Babiker, Cissy Kityo, Elly Katabira, Paula Munderi, Peter Mugyenyi, James Hakim, Janet Darbyshire, Diana M Gibb, Charles F Gilks, DART Trial Team
Published 2012-01-01